<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Leticia Campo | Yau Research Group</title>
    <link>http://localhost:1313/author/leticia-campo/</link>
      <atom:link href="http://localhost:1313/author/leticia-campo/index.xml" rel="self" type="application/rss+xml" />
    <description>Leticia Campo</description>
    <generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Wed, 01 Jan 2025 00:00:00 +0000</lastBuildDate>
    <image>
      <url>http://localhost:1313/media/icon_hu_7613a4a452ac7087.png</url>
      <title>Leticia Campo</title>
      <link>http://localhost:1313/author/leticia-campo/</link>
    </image>
    
    <item>
      <title>Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisions</title>
      <link>http://localhost:1313/publication/rai-2025-oxford/</link>
      <pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/rai-2025-oxford/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies</title>
      <link>http://localhost:1313/publication/rai-2024-oxford/</link>
      <pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/rai-2024-oxford/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Oxford classic links epithelial-to-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers</title>
      <link>http://localhost:1313/publication/hu-2021-oxford/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>http://localhost:1313/publication/hu-2021-oxford/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
